Disease-Modifying Agents for Multiple Sclerosis

Authors:

Abstract
Multiple sclerosis (MS) is a chronic autoimmune disease of the CNS. Currently, six medications are approved for immunmodulatory and immunosuppressive treatment of the relapsing disease course and...

This publication has 263 references indexed in Scilit: